285130

SKCHEM is a South Korean chemical and life sciences company operating through Green Chemicals and Life Science business segments. The Green Chemicals segment produces high-functionality copolyester resins, DMT, coating and adhesive polyester resins, bio-based polyols, and chemically recycled PET, serving customers in the automotive, electronics, packaging, and construction industries across Asia, Europe, and the Americas. Key product brands include SKYGREEN, ECOZEN, ECOTRIA, SKYDMT, SKYBON, SKYPURA, SKYPEL, SKYTRA, PO3G, and SKYPET CR. The Life Science segment develops and markets pharmaceuticals, including natural medicine-based arthritis treatments, blood circulation improvers, and transdermal patches, alongside its subsidiary SK Bioscience, which manufactures vaccines and provides CDMO services. SKCHEM also operates SK Multiutility, a subsidiary that supplies steam and electricity to industrial zones. The company maintains production facilities in South Korea and China, with regional offices in the United States, Germany, Japan, and Malaysia. Notable partnerships include a joint development agreement with Sanofi for a 21-valent pneumococcal vaccine and the acquisition of IDT Biologika, a German CDMO provider. The company was founded in 1969.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Specialty Chemicals Homepage skchemicals.com
Sector Basic Materials IR page skchemicals.com/ir
Tags
copolyester resins, chemical recycling, bio-based polyols, pharmaceuticals, vaccines, cdmo, industrial energy supply, adhesive resins, thermoplastic elastomers, SKYGREEN, ECOZEN, ECOTRIA, SKYDMT, SKYBON, SKYPURA, SKYPEL, SKYTRA, PO3G, SKYPET CR, Joins, Ginkxin F, Rivastigmine Patch, Emvix S, Trast, SK Bioscience, IDT Biologika, SK Multiutility, Shuye, RIC
Press page —

Metrics

Valuation  
Market cap ₩ 1.124T
Market cap (USD) $ 827.304M
P/E 156.91
PEG —
P/BV 0.46
P/S 0.43
P/OCF 7.34
P/FCF -6.34
Dividend yield —
Turnover / mcap —
Returns  
ROE 2.0%
ROI 2.0%
ROIC >-0.01%
Profit margin 1.9%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -38.4%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score -5.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Revenue 2.365T 1.737T 1.749T 1.829T 2.09T 1.215T 1.427T 1.368T 87.836B
Net profit 44.646B 8.839B 39.864B 191.266B 168.14B 254.321B 10.597B 6.028B -8.536B
Free cash flow -149.204B -511.441B -229.782B -476.683B 371.129B — -4.538B -14.572B -19.157B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Share price 41.917K — — — — — — — —
P/FCF -5.44 — — — — — — — —

Filed figures

Figure Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (KRW) 204B 196B 171B 233B 367B 260B 180B 368B 343B
↳ YoY growth -4.2% -12.6% +36.1% +57.3% -29.0% -30.7% +104.2% -7.0%
↳ 5y CAGR +5.0% -1.6% +16.6% +8.0%
Borrowings, current (KRW) 404B 326B 440B 205B 11.7B 436B 264B 430B 478B
Borrowings, non-current (KRW) 229B 181B 72.9B 31.1B — 7.17B 473B 1.2T 1.66T
Bonds payable (KRW) — — — — — 155B 165B 219B 466B
Lease liabilities (KRW) 5.97B 4.94B 58.5B 12.4B 11.1B 24.9B 16.7B 24.5B 22.8B
Cash and deposits (KRW) 155B 45.3B 184B 86.8B 256B 400B 396B 542B 568B
Intangible assets (KRW) 47.4B 38.3B 37.4B 37B 44.4B 51.8B 54.2B 163B 228B
Right-of-use assets (KRW) — — 58.2B 16.1B 15.4B 28.6B 35.3B 45.3B 42.4B
Net debt (borrowings + leases - cash) (KRW) 478B 461B 388B 161B -233B 68.1B 357B 1.12T 1.59T
Cash flow detail
Operating cash flow (KRW) -10.7B 67.4B 122B 247B 509B -187B 146B -89.3B 236B
Purchases of property, plant and equipment (KRW) -8.49B -81.9B -127B — -138B -288B -376B -422B -385B
Purchases of intangible assets (KRW) -301M -2.56B -3.17B -2.31B -6.65B -12.6B -10.7B -18.2B -81.3B
Dividends paid (cash effect) (KRW) — — -5.28B -6.01B -26.1B -67.2B -29.9B -17.6B -22.5B
Share buybacks (cash effect) (KRW) — -1.32B — -4.43B -3.17B -50B 0.00 0.00 —
Interest paid (cash effect) (KRW) -2.28B -31.2B -33B -24.4B -14.7B -17.6B -29.6B -39.7B -47.9B
Income taxes paid (cash effect) (KRW) -111M -3.72B -19.2B -21.1B -107B -185B -51B — —
Free cash flow (OCF - PPE - intangibles) (KRW) -19.5B -17.1B -7.7B — 364B -487B -241B -530B -230B
Income detail
Total comprehensive income (KRW) -10B -18.3B 985M 252B 268B 246B -24.2B 86.2B 94.7B
Comprehensive income to owners (KRW) -8.78B 4.36B 6.59B 251B 169B 203B -12.7B 66.6B 74.4B
Reported Mar 30, 2020 Aug 19, 2019 Mar 30, 2020 Apr 28, 2021 Mar 18, 2024 Mar 18, 2025 Mar 18, 2025 Mar 18, 2025 Mar 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

영업(잠정)실적(공정공시) Bull 0 Bear 5 Results

Prompts

SKCHEM (ticker 285130), listed in South Korea.

ETFs Holding SKCHEM

ETF Weight in ETF Shares Market value As of
AVEE 0.03% 1,174 $ 34.07K Nov 16, 2026
DEXC 0.01% 711 $ 21.296K Nov 12, 2026
DFEV 0.01% 4,337 $ 129.903K Nov 12, 2026
DFSE 0.00% 587 $ 17.582K Nov 12, 2026
DFEM 0.00% 8,954 $ 268.193K Nov 12, 2026
DFAE 0.00% 4,982 $ 149.222K Nov 12, 2026
DFAX 0.00% 3,625 $ 108.577K Nov 12, 2026
AVEM 0.00% 25,070 $ 727.537K Nov 16, 2026
AVSE 0.00% 298 $ 8,648.03 Nov 16, 2026
AVXC 0.00% 531 $ 15.41K Nov 16, 2026